The issue of suicide risk among prostate cancer patients is back on the table again as a consequence of a presentation at the ongoing annual meeting of the European Association of Urology in Copenhagen, Denmark. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Diagnosis, England, risk, suicide | 12 Comments »
According to news reports this morning, the National Institute for Health and Care Excellence (NICE) in England has changed its tune about covering cabazitaxel (Jevtana) as a treatment for men with metastatic, castration-resistant prostate cancer (mCRPC). … READ NORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cabazitaxel, England, NICE | Leave a comment »
A newly published article in the British Medical Journal has shown that black males in England are twice as likely to be diagnosed with prostate cancer as white males, and are twice as likely to die of prostate cancer too. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: asian, black, England, ethnicity, incidence, mortality, race, white | 1 Comment »
According to a report on the PharmaFile web site, the National Institute for Health and Care Excellence (NICE) in England has rejected Dendreon’s application for coverage of the costs of treatment with sipuleucel-T (Provenge) for the second time in less than a year. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: England, NICE, Provenge, sipuleucel-T | 3 Comments »
The National Institute for Health and Clinical Excellence (NICE) in the UK has issued a statement that, according to preliminary draft guidelines, it has rejected the use of sipuleucel-T (Provenge) to treat patients with metastatic prostate cancer before they have received chemotherapy. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cost, England, NICE, Provenge, sipuleucel-T, value | 3 Comments »
According to a report in the Daily Telegraph this morning, there is significant variation is prostate cancer mortality rates across England. … READ MORE …
Filed under: Uncategorized | Tagged: England, mortality, rate | 11 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 